Company
| Firm name | Eighty-Eighty Therapeutics Co., Ltd. |
| Representative | Founder and CEO Hiroshi Yamamoto |
| Establishment | 2019/09 (as H&L consulting service), 2023/06 (convert to Eighty-Eighty TA) |
| HQ | Shibuya, Tokyo |
| Business | Biotech (Drug Discovery, R&D, Regulatory, Commercialization) Healthcare Business Consulting New Company Creation (NewCo, In-Licensed Product for R&D, Commercialization) |
| Stakeholders | Founder and others |
| Partner | Researchtransfer http://www.researchtransfer.de/ Tsukishima Kachidoki law firm |
| Earnings | 45M JPY + SO (2023/08) |
